Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK, Colas RA, Dalli J, Chiang N, Serhan CN, Welty FK.
Elajami TK, et al. Among authors: dalli j.
FASEB J. 2016 Aug;30(8):2792-801. doi: 10.1096/fj.201500155R. Epub 2016 Apr 27.
FASEB J. 2016.
PMID: 27121596
Free PMC article.
Clinical Trial.
Together, they suggest that low vascular SPMs may enable progression of chronic vascular inflammation predisposing to coronary atherosclerosis and to thrombosis.-Elajami, T. K., Colas, R. A., Dalli, J., Chiang, N., Serhan, C. N., Welty, F. K. Specialized proresolvin …
Together, they suggest that low vascular SPMs may enable progression of chronic vascular inflammation predisposing to coronary atheroscleros …